Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFA vs OA on Cardiac Index During Total Hip Arthroplasty
NCT05446623Phase 3Completed
- Sponsor
- Centre Hospitalier de Montauban
- Start
- Jan 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in hip arthropathy, sponsored by Centre Hospitalier de Montauban. Started Jan 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hip arthropathy
Beyond the preview
Go deeper on NCT05446623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05446623.